CBS 2019
CBSMD教育中心
English

Acute Coronary Syndrom

科研文章

荐读文献

Coronary CT Angiography and 5-Year Risk of Myocardial Infarction Heart rate, pulse pressure and mortality in patients with myocardial infarction complicated by heart failure Early versus delayed invasive intervention in acute coronary syndromes The Wait for High-Sensitivity Troponin Is Over—Proceed Cautiously Improvement of Clinical Outcome in Patients With ST-Elevation Myocardial Infarction Between 1999 And 2016 in China : The Prospective, Multicenter Registry MOODY Study Acute Myocardial Injury in Patients Hospitalized With COVID-19 Infection: A Review Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock Cardiac Shock Care Centers: JACC Review Topic of the Week Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome

Original Research2019 Apr 1. [Epub ahead of print]

JOURNAL:Circulation. Article Link

Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction: A Multicenter Study

Komatsu Y, Hocini M, Nogami A et al. Keywords: refractory ventricular fibrillation storm; post MI; catheter Ablation; survival; mortality

ABSTRACT


BACKGROUND - Ventricular fibrillation (VF) storm after myocardial infarction (MI) is a life-threatening condition that necessitates multiple defibrillations. Catheter ablation is a potentially effective treatment strategy for VF storm refractory to optimal medical treatment. However, its impact on patient survival has not been verified in a large population.


METHODS - We conducted a multicenter, retrospective observational study involving consecutive patients who underwent catheter ablation of post-MI refractory VF storm without preceding monomorphic ventricular tachycardia. The target of ablation was the Purkinje-related ventricular extrasystoles triggering VF. The primary outcome was in-hospital and long-term mortalities. Univariate logistic regression and Cox proportional-hazards analysis were used to evaluate clinical characteristics associated with in-hospital and long-term mortalities, respectively.


RESULTS - One-hundred ten patients were enrolled (65±11years; 92 men; left ventricular ejection fraction [LVEF] 31±10%). VF storm occurred at acute phase of MI (4.5±2.5 days after the MI onset during index hospitalization for MI) in 43 (39%) patients, subacute (>1 week) in 48 (44%), and remote (>6 months) in 19 (17%). The focal triggers were found to originate from the scar border zone in 88 (80%) patients. During in-hospital stay after ablation, VF storm subsided in 92 (84%) patients. Overall, 30 (27%) in-hospital deaths occurred. The duration from the VF occurrence to the ablation procedure was associated with in-hospital mortality (odds ratio for each one-day increase: 1.11; 95% confidence interval [CI]: 1.03-1.20; p=0.008). During follow-up after discharge from hospital, only one patient developed recurrent VF storm. However, 29 (36%) patients died with a median survival time of 2.2 years (interquartile range: 1.2-5.5 years). Long-term mortality was associated with LVEF<30% (hazard ratio [HR]: 2.54; 95%CI: 1.21-5.32; p=0.014), New York Heart Association class III (HR: 2.68; 95%CI: 1.16-6.19; p=0.021), a history of atrial fibrillation (HR: 3.89; 95%CI: 1.42-10.67; p=0.008), and chronic kidney disease (HR: 2.74; 95%CI: 1.15-6.49; p=0.023).


CONCLUSIONS - In patients with MI presenting with focally-triggered VF storm, catheter ablation of culprit triggers is life-saving and appears to be associated with short- and long-term freedom from recurrent VF storm. Mortality over long-term follow-up is associated with the severity of underlying cardiovascular disease and comorbidities in this specific patient population.